Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic and pharmacodynamic comparison of two Thymoglobuline dosing regimens in kidney transplantation
2009-012673-35Phase 2Active
- Sponsor
- CHRU Tours
- Start
- May 2009
- Modality
- Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of antithymocyte globulin rabbit in kidney transplant (2 arms), sponsored by CHRU Tours. Primary endpoint: Pharmacokinetic parameters of Thymoglobuline and active Thymoglobuline. Started May 2009; status: active.
02
Drugs
antithymocyte globulin rabbit
03
Conditions
kidney transplant
Beyond the preview
Go deeper on 2009-012673-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012673-35.